ArticleIn silico pharmacology2025

In silico docking and ADMET studies on clinical targets for type 2 diabetes correlated to in vitro inhibition of pancreatic alpha-amylase and alpha-glucosidase by rutin, caffeic acid, p-coumaric acid, and vanillin.

Jamie McMillan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.